tacrolimus

Managing treatment options for atopic keratoconjunctivitisEye or eyelid involvement in atopic dermatitis is relatively uncommon. However, the frequency and severity of corneal complications may accompany atopic keratoconjunctivitis and lead to vision loss. In all but the mildest cases of AKC, treatment typically consists of corticosteroids; calcineurin inhibitors may be added in more severe cases.
Risk review supports safety of corneal crosslinkingSevere complications are rare (< 1%) after corneal crosslinking for progressive keratoconus. Some are preventable, some are manageable, but some may lead to a need for corneal transplantation
Taking on tacrolimus to treat vernal keratoconjunctivitisTacrolimus 0.01% was effective for the treatment of vernal keratoconjunctivitis in a study with 62 patients.
Tacrolimus drops associated with improvement of refractory allergic ocular diseaseAccording to a study recently published in the British Journal of Ophthalmology from Kochi Medical School in Japan, “tacrolimus eye drops are highly effective in treating allergic conjunctivitis with proliferative lesions and/or corneal involvement, and may reduce or replace topical steroid use.”
Urology Product Preview April 2014Drugs and devices in the pipeline from Astellas Pharma, Medivation, Repros Therapeutics, Metamark Genetics, Argos Therapeutics, S1 Biopharma, Ipsen, Sprout Pharmaceuticals, Antigen Express, Generex Biotechnology, Veloxis Pharmaceuticals, and Absorption Pharmaceuticals.
October 2013 New Urology Products & ServicesThe latest products and services from Cook Medical, American Medical Systems, Dialog Medical, Astellas Pharma U.S., Giffen Solutions, the Société Internationale d’Urologie, Merck Consumer Care, and the Bladder Cancer Advocacy Network.
Product PreviewDrugs and devices in the pipeline from AVEO Oncology; Astellas Pharma Global Development, Inc.; Nymox Pharmaceutical Corp.; TheraVida, Inc.; and Argos Therapeutics.